Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
NCT05061758
A Trial of LY3056480 in Patients With SNLH
Phase: Phase 2
Role: Lead Sponsor
Start: Sep 30, 2022
Completion: Mar 31, 2025